期刊文献+

胃癌组织中RAGE和配体HMGB1表达的临床研究 被引量:3

Clinical study on the expression of receptor for advanced glycation end product and its ligand high mobility group B1 in gastric cancer
下载PDF
导出
摘要 目的:分析胃癌及相应癌旁组织中的晚期糖基化终产物受体(receptor for advanced glycation end product,RAGE)及其配体高迁移率族蛋白B1(high mobility group box-1,HMGB1)的表达情况,探讨RAGE、HMGB1表达与胃癌患者临床病理因素的关系以及两者对预后的影响。方法:应用免疫组织化学的方法检测109例胃癌组织和30例癌旁组织中RAGE和HMGB1的表达,运用美国Media Cybernetics公司Image-Pro誖Plus 6.2软件分析每张切片的阳性着色的积分吸光度值。结果:相对于癌旁组织,胃癌组织内RAGE和HMGB1的表达升高(P<0.001)。RAGE的表达情况与肿瘤浸润深度、淋巴结转移及TNM分期显著相关(P值均<0.05);HMGB1的表达情况与肿瘤组织分化程度和肿瘤转移相关(P=0.023);RAGE的表达与患者无病生存期相关(P<0.001),而HMGB1的表达与患者术后的无病生存期无关。结论:HMGB1-RAGE信号偶联与胃癌的侵袭和转移相关,患者胃癌标本中RAGE的表达影响患者预后,HMGB1-RAGE信号偶联是胃癌治疗的可能靶点之一。 Objective:To investigate the expression of receptor for advanced glycation end product (RAGE) and its'ligand:high mobility group protein B1 in the gastric cancer and tumor-adjacent tissues,then we analyzed the relationship between the expression of HMGB1 and RAGE and clinicopathological parameters in patients with gastric cancer,and subsequently,comprehensive analysis was made between the expression of RAGE and HMGB1 and the prognosis of gastric cancer patients with regard to the role and influence.Methods:The expression of RAGE and HMGB1 in 109 cases of gastric carcinoma and 30 cases of cancer tissue were detected by immunohistochemistry,and the Media Cybernetics Image-Pro? Plus 6.2 software (USA) was used to analyze each slice of positive staining of integrated optical density,its' values and results were statistically processed.Results:Compared with tumor-adjacent tissues,the increased expression of HMGB1 and RAGE were found in gastric tissue,and the difference has statistically significant (P<0.001).Integrated with clinical pathology indicators,the expression of RAGE and depth of tumor invasion,lymph node metastasis and TNM stage were significantly statistics confirmed correlated (P values<0.05),The relation between the expression of HMGB1 and tumor differentiation,tumor metastasis was related (P=0.023),Through the Kaplan-Meier method,the patients' survival analysis were confirmed to be associated between the expression of RAGE and disease-free survival in gastric cancer patients (P<0.001),HMGB1 and the expression of disease-free survival of patients was irrelevant.Conclusion:The coupled signaling of HMGB1-RAGE is confirmed to be with the invasion and metastasis in gastric cancer,and the degree of RAGE expression in gastric cancer specimens affecting the prognosis of patients.The HMGB1-RAGE signaling pathway may be one of the targets in the treatments with gastric cancer.
出处 《中国现代普通外科进展》 CAS 2013年第10期761-765,共5页 Chinese Journal of Current Advances in General Surgery
基金 黑龙江省卫生厅科研课题(2010-153)
关键词 胃肿瘤 晚期糖基化终末产物受体 高迁移率族蛋白B1 Gastric neoplasms Advanced glycation end products receptor High mobility group protein B1
  • 相关文献

参考文献19

  • 1Kuniyasu H,Oue N,Wakikawa A,et al.Expression of receptors for advanced glycationend-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer[J].Pathol,2002,196(2):163-170. 被引量:1
  • 2Ishiguro H,Nakaigawa N,Miyoshi Y,et al.Receptor for advanced glycation end products (RAGE) and its ligand,amphoterin are over expressed and associated with prostate cancer development[J].Prostate,2005,64 (1):92-100. 被引量:1
  • 3Kuniyasu H,Chijhara Y,Takahashi T.Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer[J].Oncol Rep,2003,10(2):445-448. 被引量:1
  • 4Takada M,Hirata K,Ajiki T,et al.Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells[J].Hepatogastroenterology,2004,51 (58):928-930. 被引量:1
  • 5Taguchi A,Blood DC,del Toro G,et al.Blockade of RAGE-am-photerin signalling suppresses tumour growth and metastases[J].Nature,2000,405 (6784):354-360. 被引量:1
  • 6Sims GP,Rowe DC,Rietdijk ST,et al.HMGB-1 and RAGE in inflammation and cancer[J].Annu Rev Immunol,2010,28(1):367-388. 被引量:1
  • 7Heikki Rauvala,Ari Rouhiainen.RAGE as a receptor of HMGBI (Amphoterin):Roles in Health and Disease[J].Curr Mol Med,2007,7:725-734. 被引量:1
  • 8Craig D,Logsdon,Maren K,et al.RAGE and RAGE Ligands in Cancer[J].Curr Mol Med,2007,7:777-789. 被引量:1
  • 9Ito N,DeMarco RA,Mailliard RB,et al.Cytolytic cells induce HMGB1 release from melanoma cell lines[J].J Leukoc Biol,2007,81(1):75-83. 被引量:1
  • 10栾正刚,张成,葛春林,马晓春,郭仁宣.重症急性胰腺炎大鼠HMGB1表达与肠黏膜屏障损害的关系[J].中国现代普通外科进展,2008,11(1):17-20. 被引量:4

二级参考文献35

  • 1黄庆先,王国斌,孙念峰,王春友.高迁移率族蛋白框1反义核酸抑制人胰腺癌细胞系PCNA-1侵袭的研究[J].癌症,2004,23(9):1036-1040. 被引量:16
  • 2Takada M, Koizumi T, Toyama H, et al. Differential expression of RAGE in human pancreatic carcinoma cells. Hepatogastroenterology, 2001, 48: 1577-1578. 被引量:1
  • 3Taguchi A, Blood DC, del Toro G, et al. Blockade of RAGE-amphoterin signalling suppresses turnout growth and metastasis.Nature, 2000,405: 354-360. 被引量:1
  • 4Thomas JO, Travers AA. HMG1 and 2, and relate 'architectural' DNA binding proteins. Trends Biochem Sci,2001, 26: 167-174. 被引量:1
  • 5Miüller S, Scaffidi P, Degryse B, et al. New EMBO members' review:the double life of HMGB1 chromatin protein:architectural factor and extracellular signal. EMBO J, 2001, 20:4337-4340. 被引量:1
  • 6Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem, 1991, 266: 16730-16735. 被引量:1
  • 7Kuniyasu H, Chihara Y, Takahashi T, et al. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. Oncol Rep, 2003, 10: 445-448. 被引量:1
  • 8Kuniyasu H, Chihara Y, Kondo H, et al. Differential effects between amphoterin and advanced glycation end products on colon cancer cell. Int J Cancer, 2003, 104:722-727. 被引量:1
  • 9Garside P, Millington O, Smith KM. The anatomy of mucosal immune responses[J]. Ann N Y Acad Sci, 2004,1029: 9-15. 被引量:1
  • 10Gloor B, Muller CA, Worni M, et al. Late mortality in patients with severe acute pancreatitis [J]. Br J Surg, 2001, 88(7):975-979. 被引量:1

共引文献12

同被引文献14

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部